Biovail Reports First-Quarter 2008 Financial Results
genengnews.com: Genetic Engineering genengnews.com
genengnews.com     May 9, 2008            

News source: Business Wire Biovail Corporation (NYSE/TSX: BVF) today announced its financial results for the three-month period ended March 31, 2008. Product revenues for the first quarter of 2008 were $196.9 million, compared with $238.0 million in the first quarter of... [read full story]                    


View all news articles about*:
Banking Cardiovascular Care Corporate Drugs Earnings Emergency Finance Financial General Generic Health Hospital Hospitals Insurance Investing Markets Medication Medicines Ortho-McNeil Performance Pharmaceuticals Psychiatric Remedies Stock Ward
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

STOCK PICKS: Top 5 Small-Caps for Sept. 5 (at TheStreet.com)

yahoo.com     2 mins ago   1 related          

Each business day, TheStreet.com Ratings compiles a list of the top five stocks in five categories -- fast-growth, all-around value, large-cap, mid-cap and small-cap -- and publishes these lists in the Ratings section...                    

comments

                   

Breast MRIs delay cancer treatment by weeks: study (Reuters)

yahoo.com     1 hr ago   2 related          

Reuters - Women with newly diagnosed breast cancer who get an MRI scan wait about three weeks longer before their surgery and are far more likely to get a mastectomy than women who have only a mammogram, U.S. researchers...                    

comments

                   

Amgen And Wyeth Statement On The FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF)...

medicalnewstoday.com     4 hrs ago          

Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in...                    

comments

                   

Fund manager prescribes fast-growing health care stocks

menafn.com     yesterday          

Healthy choices Fund manager prescribes AngioDynamics, Magellan Health, KV Pharmaceutical By Val Brickates Kennedy, MarketWatch BOSTON (Menafn - "We like companies with solid core businesses that can go to another level...                    

comments